BRIEF-Gilead CEO Says Remdesivir Working Across All Known Variants Including Omicron - CNBC Interview

BRIEF-Gilead CEO Says Remdesivir Working Across All Known Variants Including Omicron - CNBC Interview

Jan 10 (Reuters) -

* GILEAD CEO SAYS REMDESIVIR WORKING ACROSS ALL KNOWN VARIANTS INCLUDING OMICRON - CNBC INTERVIEW

* GILEAD CEO SAYS WORKING ON AN ORAL FORM OF REMDESIVIR; GOING INTO EARLY STAGE TRIALS NOW - CNBC INTERVIEW

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.